Clinical Trial Update: Amlodipine for Myocardial Iron in Thalassemia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating amlodipine for myocardial iron overload in thalassemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia

Drugs mentioned

• Amlodipine (amlodipine)

Snippet

Sponsor: Aga Khan University | Conditions: Thalassemia | Phase 2, Phase 3 | Status: COMPLETED